Trial intelligence / Profile preview

Lidocaine for Rocuronium Injection Pain

NCT06865300Completed

Sponsor
Giresun University
Start
Jul 2023
Primary completion
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of lidocaine (3 arms), sponsored by Giresun University. Primary endpoint: Visual Analog Scale at 5 months. Started Jul 2023; status: completed.

02

Drugs

lidocaine

Beyond the preview

Go deeper on NCT06865300.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06865300.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call